Literature DB >> 25877470

Structural determinants of human proton-coupled folate transporter oligomerization: role of GXXXG motifs and identification of oligomeric interfaces at transmembrane domains 3 and 6.

Mike R Wilson1, Sita Kugel1, Jenny Huang1, Lucas J Wilson1, Patrick A Wloszczynski1, Jun Ye2, Larry H Matherly3, Zhanjun Hou4.   

Abstract

The human proton-coupled folate transporter (hPCFT) is expressed in solid tumours and is active at pHs characterizing the tumour microenvironment. Recent attention focused on exploiting hPCFT for targeting solid tumours with novel cytotoxic anti-folates. hPCFT has 12 transmembrane domains (TMDs) and forms homo-oligomers with functional significance. The hPCFT primary sequence includes GXXXG motifs in TMD2 (G(93)XXXG(97)) and TMD4 (G(155)XXXG(159)). To investigate roles of these motifs in hPCFT function, stability and surface expression, we mutated glycine to leucine to generate single or multiple substitution mutants. Only the G93L and G159L mutants preserved substantial [(3)H]methotrexate (Mtx) transport when expressed in hPCFT-null (R1-11) HeLa cells. Transport activity of the glycine-to-leucine mutants correlated with surface hPCFT by surface biotinylation and confocal microscopy with ECFP*-tagged hPCFTs, suggesting a role for GXXXG in hPCFT stability and intracellular trafficking. When co-expressed in R1-11 cells, haemagglutinin-tagged glycine-to-leucine mutants and His10-tagged wild-type (WT) hPCFT co-associated on nickel affinity columns, suggesting that the GXXXG motifs are not directly involved in hPCFT oligomerization. This was substantiated by in situ FRET experiments with co-expressed ECFP*- and YFP-tagged hPCFT. Molecular modelling of dimeric hPCFT structures showed juxtaposed TMDs 2, 3, 4 and 6 as potential structural interfaces between monomers. hPCFT cysteine insertion mutants in TMD3 (Q136C and L137C) and TMD6 (W213C, L214C, L224C, A227C, F228C, F230C and G231C) were expressed in R1-11 cells and cross-linked with 1,6-hexanediyl bismethanethiosulfonate, confirming TMD juxtapositions. Altogether, our results imply that TMDs 3 and 6 provide critical interfaces for formation of hPCFT oligomers, which might be facilitated by the GXXXG motifs in TMD2 and TMD4.
© 2015 Authors; published by Portland Press Limited.

Entities:  

Keywords:  anti-folate; cross-linking; folate; oligomerization; proton-coupled folate transporter; transporter

Mesh:

Substances:

Year:  2015        PMID: 25877470      PMCID: PMC4713120          DOI: 10.1042/BJ20150169

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

1.  The GxxxG motif: a framework for transmembrane helix-helix association.

Authors:  W P Russ; D M Engelman
Journal:  J Mol Biol       Date:  2000-02-25       Impact factor: 5.469

2.  Transmembrane domain mediated self-assembly of major coat protein subunits from Ff bacteriophage.

Authors:  Roman A Melnyk; Anthony W Partridge; Charles M Deber
Journal:  J Mol Biol       Date:  2002-01-04       Impact factor: 5.469

3.  Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods.

Authors:  Zhanjun Hou; Sarah E Stapels; Christina L Haska; Larry H Matherly
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Properties of the Arg376 residue of the proton-coupled folate transporter (PCFT-SLC46A1) and a glutamine mutant causing hereditary folate malabsorption.

Authors:  Kris Mahadeo; Ndeye Diop-Bove; Daniel Shin; Ersin Selcuk Unal; Juliana Teo; Rongbao Zhao; Min-Hwang Chang; Andreas Fulterer; Michael F Romero; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-04       Impact factor: 4.249

Review 6.  The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.

Authors:  Larry H Matherly; Mike R Wilson; Zhanjun Hou
Journal:  Drug Metab Dispos       Date:  2014-01-06       Impact factor: 3.922

7.  Targeting the proton-coupled folate transporter for selective delivery of 6-substituted pyrrolo[2,3-d]pyrimidine antifolate inhibitors of de novo purine biosynthesis in the chemotherapy of solid tumors.

Authors:  Sita Kugel Desmoulin; Yiqiang Wang; Jianmei Wu; Mark Stout; Zhanjun Hou; Andreas Fulterer; Min-Hwang Chang; Michael F Romero; Christina Cherian; Aleem Gangjee; Larry H Matherly
Journal:  Mol Pharmacol       Date:  2010-07-02       Impact factor: 4.436

8.  Functional loss of the reduced folate carrier enhances the antitumor activities of novel antifolates with selective uptake by the proton-coupled folate transporter.

Authors:  Sita Kugel Desmoulin; Lei Wang; Lisa Polin; Kathryn White; Juiwanna Kushner; Mark Stout; Zhanjun Hou; Christina Cherian; Aleem Gangjee; Larry H Matherly
Journal:  Mol Pharmacol       Date:  2012-06-26       Impact factor: 4.436

Review 9.  Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.

Authors:  Zhanjun Hou; Larry H Matherly
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

10.  A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier.

Authors:  Rongbao Zhao; Feng Gao; Marie Hanscom; I David Goldman
Journal:  Clin Cancer Res       Date:  2004-01-15       Impact factor: 12.531

View more
  6 in total

Review 1.  The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer.

Authors:  Larry H Matherly; Zhanjun Hou; Aleem Gangjee
Journal:  Cancer Chemother Pharmacol       Date:  2017-11-10       Impact factor: 3.333

2.  Impact of posttranslational modifications of engineered cysteines on the substituted cysteine accessibility method: evidence for glutathionylation.

Authors:  Rongbao Zhao; Mitra Najmi; Srinivas Aluri; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-25       Impact factor: 4.249

3.  Human bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers.

Authors:  Paresh P Chothe; Lindsay C Czuba; Robyn H Moore; Peter W Swaan
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-12-01       Impact factor: 3.747

4.  Functional and mechanistic roles of the human proton-coupled folate transporter transmembrane domain 6-7 linker.

Authors:  Mike R Wilson; Zhanjun Hou; Lucas J Wilson; Jun Ye; Larry H Matherly
Journal:  Biochem J       Date:  2016-08-11       Impact factor: 3.857

5.  Identification of the amino acid residue responsible for the myricetin sensitivity of human proton-coupled folate transporter.

Authors:  Takahiro Yamashiro; Tomoya Yasujima; Kinya Ohta; Katsuhisa Inoue; Hiroaki Yuasa
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

Review 6.  The evolving biology of the proton-coupled folate transporter: New insights into regulation, structure, and mechanism.

Authors:  Zhanjun Hou; Aleem Gangjee; Larry H Matherly
Journal:  FASEB J       Date:  2022-02       Impact factor: 5.834

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.